{"version":"1.0","provider_name":"Terveysteknologia","provider_url":"https:\/\/teknologiateollisuus.fi\/healthtech","title":"Abacus Diagnostican COVID-19 -testille poikkeuslupa","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"d5saIEWTT6\"><a href=\"https:\/\/teknologiateollisuus.fi\/healthtech\/abacus-diagnostican-covid-19-testille-poikkeuslupa\/\">Abacus Diagnostican COVID-19 -testille poikkeuslupa<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/teknologiateollisuus.fi\/healthtech\/abacus-diagnostican-covid-19-testille-poikkeuslupa\/embed\/#?secret=d5saIEWTT6\" width=\"600\" height=\"338\" title=\"&#8221;Abacus Diagnostican COVID-19 -testille poikkeuslupa&#8221; &#8212; Terveysteknologia\" data-secret=\"d5saIEWTT6\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/teknologiateollisuus.fi\/healthtech\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/06\/Abacus-Diagnostica-COVID19.jpg","thumbnail_width":843,"thumbnail_height":531,"description":"L\u00e4\u00e4kealan turvallisuus- ja kehitt\u00e4miskeskus Fimea on my\u00f6nt\u00e4nyt turkulaiselle Abacus Diagnosticalle poikkeusluvan saattaa yrityksen COVID-19 testi Suomen markkinoille. Poikkeuslupa mahdollistaa testin k\u00e4ytt\u00e4misen potilasn\u00e4ytteiden analysointiin. Testi onkin tulossa k\u00e4ytt\u00f6\u00f6n isossa osassa Suomen keskussairaaloiden laboratorioita. Abacus toimitti ensimm\u00e4iset testit asiakkaille jo maaliskuun lopussa, ja yritys on sen j\u00e4lkeen tuonut testist\u00e4 uuden, p\u00e4ivitetyn version saataville. Poikkeuslupa my\u00f6nnettiin p\u00e4ivitetylle testiversiolle.&nbsp; [&hellip;]"}